NEOG (STOCKS)
Neogen Corp
$9.300000
+0.200000 (+2.20%)
Prev close: $9.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Mikhael Nassif
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,024.36M
- Employees
- 1,456
- P/E (TTM)
- -3.24
- P/B (TTM)
- 0.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $870.54M |
| Benefits Costs and Expenses | $1.50B |
| Cost Of Revenue | $477.01M |
| Costs And Expenses | $1.50B |
| Gross Profit | $393.53M |
| Nonoperating Income/Loss | $7.79M |
| Operating Expenses | $1.03B |
| Research and Development | $19.79M |
| Other Operating Expenses | $1.01B |
| Operating Income/Loss | -$635.97M |
| Income/Loss From Continuing Operations After Tax | -$608.84M |
| Income/Loss From Continuing Operations Before Tax | -$628.11M |
| Income Tax Expense/Benefit | -$19.27M |
| Income Tax Expense/Benefit, Deferred | -$40.18M |
| Net Income/Loss | -$608.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$608.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$608.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.80 |
| Diluted Earnings Per Share | -$2.80 |
| Basic Average Shares | 217,494,861 |
| Diluted Average Shares | 217,994,861 |
| Assets | $3.36B |
| Current Assets | $590.00M |
| Inventory | $161.70M |
| Other Current Assets | $428.30M |
| Noncurrent Assets | $2.77B |
| Fixed Assets | $331.90M |
| Other Non-current Assets | $2.44B |
| Liabilities | $1.26B |
| Current Liabilities | $150.60M |
| Accounts Payable | $75.20M |
| Wages | $23.50M |
| Other Current Liabilities | $51.90M |
| Noncurrent Liabilities | $1.11B |
| Equity | $2.10B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.10B |
| Liabilities And Equity | $3.36B |
| Net Cash Flow From Operating Activities | $69.44M |
| Net Cash Flow From Operating Activities, Continuing | $69.44M |
| Net Cash Flow From Investing Activities | $58.61M |
| Net Cash Flow From Investing Activities, Continuing | $58.61M |
| Net Cash Flow From Financing Activities | -$101.20M |
| Net Cash Flow From Financing Activities, Continuing | -$101.20M |
| Net Cash Flow | $26.85M |
| Net Cash Flow, Continuing | $26.85M |
| Comprehensive Income/Loss | -$573.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$573.62M |
| Other Comprehensive Income/Loss | $35.22M |